Opioid-receptor subtype agonist-induced enhancements of sucrose intake are dependent upon sucrose concentration

Physiology and Behavior

Volumn 62, Issue 1, 1997, Pages 121-128

  Ruegg, Hildegard ^a   Yu, Wei Zhen ^a   Bodnar, Richard J ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Delta1 receptor; Delta2 receptor; Kappa1 receptor; Kappa3 receptor; Mu receptor; Opioids; Rats; Sucrose intake

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE BENZOYLHYDRAZONE; NALTREXONE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; RECEPTOR SUBTYPE; SUCROSE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEEDING BEHAVIOR; FOOD INTAKE; HYPERPHAGIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030873306     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(97)00151-0     Document Type: Article

References (66)

1. Ackroff K., Sclafani A. Sucrose-induced hyperphagia and obesity in rats fed a macronutrient self-selection diet. Physiol. Behav. 44:1988;181-187.
2. Arjune D., Bodnar R. J. Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine. Brain Res. 534:1990;313-316.
3. Bakshi V. P., Kelley A. E. Feeding induced by opioid stimulation of the ventral striatum: role of opioid receptor subtypes. J. Pharmacol. Exp. Ther. 265:1993;1253-1260.
4. Beczkowska I. W., Bowen W. D., Bodnar R. J. Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats. Brain Res. 589:1992;291-301.
5. Beczkowska I. W., Koch J. E., Bostock M. E., Leibowitz S. F., Bodnar R. J. Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats. Brain Res. 618:1993;261-270.
6. Bodnar R. J. Opioid receptor subtype antagonists and ingestion. Cooper S. J., Clifton P. J. Drug receptor subtypes and ingestive behaviour. 1996;127-146 Academic Press, London.
7. Calcagnetti D. J., Calcagnetti R. L., Fanselow M. S. Centrally administered opioid antagonists nor-binaltorphamine 16-methyl cyrenorphine and MR2266 suppress intake of a sweet solution. Pharmacol. Biochem. Behav. 35:1990;69-73.
8. Calcagnetti D. J., Reid L. D. Morphine and acceptability of putative reinforcers. Pharmacol. Biochem. Behav. 18:1983;567-569.
9. Clark J. A., Liu L., Price M., Hersh B., Edelson M., Pasternak G. W. Kappa opiate receptor multiplicity: evidence for two U50488H-sensitive K-1 subtypes and a novel K-3 subtype. J. Pharmacol. Exp. Ther. 251:1989;461-468.
10. Clarkson D. B., King B. M., Hemmer R. C., Olson G. A., Kastin A. J., Olson R. D. Naloxone decreases consumption of liquid and solid sucrose in vagotomized rats. Physiol. Behav. 29:1982;927-930.
11. Cole J. L., Leventhal L., Pasternak G. W., Bowen W. D., Bodnar R. J. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res. 678:1995;168-176.
12. Cooper S. J. Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat. Neuropharmacology. 22:1983;323-328.
13. Cooper S. J., Jackson A., Kirkham T. C., Turkish S. Endorphins opiates and food intake. Rodgers R. J., Cooper S. J. Endorphins opiates and behavioral processes. 1988;143-186 John Wiley and Sons, New York.
14. Czirr S. A., Reid L. D. Demonstrating morphine's potentiating effects on sucrose intake. Brain Res. Bull. 17:1986;639-642.
15. Drewnowski A., Krahn D. D., Demitrack M. A., Nairn K., Gosnell B. A. Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Physiol. Behav. 51:1992;371-379.
16. Gistrak M. A., Paul D., Hahn E. F., Pasternak G. W. Pharmacological actions of a novel mixed opiate agonist-antagonist: naloxone benzoylhydrazone. J. Pharmacol. Exp. Ther. 251:1989;469-476.
17. Gosnell B. A., Levine A. S., Morley J. E. The stimulation of food intake by selective agonists of mu kappa and delta opioid receptors. Life Sci. 38:1986;1081-1088.
18. Gosnell B. A., Majchrzak M. J. Centrally administered opioid peptides stimulate saccharin intake in nondeprived rats. Pharmacol. Biochem. Behav. 33:1989;805-810.
19. Gosnell B. A., Patel C. K. Centrally administered mu- and delta-opioid agonists increase operant responding for saccharin. Pharmacol. Biochem. Behav. 45:1993;979-982.
20. Heyman J. S., Mulvaney H. I., Mosberg H. I., Porreca F. Opioid delta receptor involvement in supraspinal and spinal antinociception in mice. Brain Res. 420:1987;100-108.
21. Itzhak Y., Pasternak G. W. Interaction of [D-Ser2 Leu5]-enkephalin-Thr6 (DSLET) a relatively selective delta ligand with mu 1 opioid binding sites. Life Sci. 40:1987;307-311.
22. Jiang Q., Mosberg H. I., Porreca F. Antinociceptive effects of [D-Ala2]-deltorphan II a highly selective delta agonist in vivo. Life Sci. 47:1990;PL43-47.
23. Jiang Q., Takemori A. E., Sultana M., Portoghese P. S., Bowen W. D., Mosberg H. I., Porreca F. Differential antagonism of opioid delta antinociception by [D-Ala2 Leu5 Cys6]-enkephalin (DALCE) and naltrindole 5′-isothiocyanate (5′-NTII): evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;1069-1075.
24. Kirkham T. C. Enhanced anorectic potency of naloxone in rats sham feeding 30% sucrose:reversal by repeated naloxone administration. Physiol. Behav. 47:1990;419-426.
25. Kirkham T. C., Blundell J. E. Dual action of naloxone on feeding revealed by behavioral analysis: separate effects on initiation and termination of eating. Appetite. 5:1984;45-52.
26. Kirkham T. C., Blundell J. E. Effects of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine. Pharmacol. Biochem. Behav. 25:1986;123-128.
27. Kirkham T. C., Cooper S. J. Attenuation of sham feeding by naltrexone is stereospecific: evidence for opioid mediation of orosensory reward. Physiol. Behav. 43:1988;845-847.
28. Kirkham T. C., Cooper S. J. Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiol. Behav. 44:1988;491-494.
29. Koch J. E., Pasternak G. W., Arjune D., Bodnar R. J. Naloxone benzoylhydrazone a kappa-3 opioid agonist stimulates food intake in rats. Brain Res. 581:1992;311-314.
30. Kreil G., Barra D., Simmaco M., Erspamer V., Falconari-Erspamer G., Negri L., Severini C., Corsi R., Melchiorri P. Deltorphan a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors. Eur. J. Pharmacol. 162:1989;123-128.
31. LeMagnen J., Marfaing-Jallat P., Micelli D., Devos M. Pain modulating and reward systems: a single brain mechanism. Pharmacol. Biochem. Behav. 12:1980;729-733.
32. Leventhal L., Kirkham T. C., Cole J. L., Bodnar R. J. Selective actions of central mu and kappa opioid antagonists upon sucrose intake in sham-feeding rats. Brain Res. 685:1995;205-210.
33. Levine A. S., Grace M., Portoghese P. S., Billington C. J. The effect of selective opioid antagonists on butorphanol-induced feeding. Brain Res. 637:1994;242-248.
34. Levine A. S., Morley J. E., Gosnell B. A., Billington C. J., Bartness T. J. Opioids and consummatory behavior. Brain Res. Bull. 14:1985;663-672.
35. Levine A. S., Murray S. S., Kneip J., Grace M., Morley J. E. Flavor enhances the antidipsogenic effect of naloxone. Physiol. Behav. 28:1982;23-25.
36. Levine A. S., Weldon D. T., Grace M., Cleary J. P., Billington C. J. Naloxone blocks that portion of feeding driven by sweet taste in food-restricted rats. Am. J. Physiol. 268:1995;R248-R252.
37. Lord J. A. H., Waterfield A. A., Hughes J., Kosterlitz H. Endogenous opioid peptides:multiple agonists and receptors. Nature. 267:1977;495-499.
38. Lynch W. C. Opiate blockade inhibits saccharin intake and blocks normal preference acquisition. Pharmacol. Biochem. Behav. 24:1986;833-836.
39. Lynch W. C., Libby L. Naloxone suppresses intake of highly preferred saccharin solutions in food deprived and sated rats. Life Sci. 33:1983;1909-1914.
40. Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., Gilbert P. E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
41. Mattia A., Farmer S. C., Takemori A. E., Sultana M., Portoghese P. S., Mosberg H. I., Bowen W. D., Porreca F. Spinal opioid delta antinociception in the mouse: mediation by a 5′-NTII- sensitive delta receptor subtype. J. Pharmacol. Exp. Ther. 260:1992;518-525.
42. Mattia A., Vanderah T., Mosberg H. I., Porreca F. Lack of antinociceptive cross-tolerance between [D-Pen2 D-Pen5]-enkephalin and [D-Ala2]-deltorphan II in mice: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258:1991;583-587.
43. Meyer M. E., Meyer M. E. Behavioral effects of mu opioid agonists DAMGO DALDA and PL017 on locomotor activities Pharmacol. Biochem. Behav. 46:1993;391-395.
44. Meyer M. E., Meyer M. E. Behavioral effects of opioid receptor agonists DAGO DPDPE and DAKLI on locomotor activities. Pharmacol. Biochem. Behav. 45:1993;315-320.
45. Milano W. C., Wild K. D., Hui Y., Hubbell C. L., Reid L. D. PCP THC ethanol and morphine and consumption of palatable solutions. Pharmacol. Biochem. Behav. 31:1989;893-897.
46. Morley J. E., Levine A. S., Kneip J., Grace M., Zeugner H., Shearman G. T. The K opioid receptor and food intake. Eur. J. Pharmacol. 112:1985;17-25.
47. Morley J. E., Levine A. S., Yim G. K. W., Lowy M. T. Opioid modulation of appetite. Neurosci. Biobehav. Rev. 7:1983;281-305.
48. Mosberg H. I., Hurst R., Hruby V. J. K., Galligan J. J., Burks T. F., Gee K., Yamamura H. I. Conformationally constrained cyclic enkephalins show pronounced delta receptor selectivity. Life Sci. 32:1983;2565-2569.
49. Negri L., Potenza R. L., Corsi R., Melchiorri P. Evidence for two subtypes of delta receptors in rat brain. Eur. J. Pharmacol. 196:1991;335-336.
50. Nock B., Rajpara A., O'Connor L. H., Cicero T. J. Autoradiography of [3-H]-U69593 binding sites in rat brain: evidence for K opioid receptor subtypes. Eur. J. Pharmacol. 154:1988;27-34.
51. Parker L. A., Maier S., Rennie M., Crebolder J. Morphine- and naltrexone-induced modification of palatability: analysis by the taste reactivity test. Behav. Neurosci. 106:1992;999-1010.
52. Pasternak G. W., Wood P. L. Multiple mu opiate receptors. Life Sci. 38:1986;1889-1896.
53. Paul D., Levison J. A., Howard D. H., Pick C. G., Hahn E. F., Pasternak G. W. Naloxone benzoylhydrazone (NalBxoH) analgesia. J. Pharmacol. Exp. Ther. 255:1990;769-774.
54. Porreca F., Heyman J. S., Mosberg H. I., Omnaas J. R., Vaught J. L. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of (D-Pen2 D-Pen5)-enkephalin in the mouse. J. Pharmacol. Exp. Ther. 241:1987;393-400.
55. Ramirez I. Why do sugars taste good? eurosci. Biobehav. Rev. 14:1990;125-134.
56. Reisine T., Bell G. I. Molecular biology of opioid receptors. Trends Neurosci. 16:1993;506-510.
57. Rockwood G. A., Reid L. D. Naloxone modifies sugar-water intake in rats drinking with open gastric fistulas. Physiol. Behav. 29:1982;1175-1178.
58. Rothman R. B., Bykov V., deCosta B. R., Jacobson A. E., Rice K. C., Brady L. S. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Peptides. 11:1990;311-331.
59. Siviy S. M., Calcagnetti D. J., Reid L. D. Opioids and palatability. Hoebel B. G., Novin D. The neural basis of feeding and reward. 1982;517-524 Haer Institute, Brunswick ME.
60. Siviy S. M., Reid L. D. Endorphinergic modulation of acceptability of putative reinforcers. Appetite. 4:1983;249-257.
61. Sofuoglu M., Portoghese P. S., Takemori A. E. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analogue (NTB) in mice: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257:1991;676-680.
62. Uhl G. R., Childers S. R., Pasternak G. W. An opiate receptor gene family reunion. Trends Neurosci. 17:1994;89-93.
63. VanVoigtlander P. F., Lahti R. A., Ludens J. H. U50488H: a selective and structurally novel nonmu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224:1993;7-11.
64. Welch C. C., Kim E-M., Grace M. K., Billington C. J., Levine A. S. Palatability-induced hyperphagia increases hypothalamic dynorphin peptide and mRNA levels. Brain Res. 721:1996;126-131.
65. Yu W-Z., Ruegg H., Bodnar R. J. Delta and kappa opioid receptor subtypes and ingestion: antagonist and glucoprivic effects. Pharmacol. Biochem. Behav. 56:1997;353-361.
66. Zukin R. S., Eghbalai M., Olive D., Unterwald E. M., Tempel A. Characterization and visualization of rat and guinea pig brain K opioid receptors: evidence for K-1 and K-2 opioid receptors. Proc. Natl. Acad. Sci. USA. 85:1988;4061-4065.